NUTEX Investments Past Earnings Performance
Past criteria checks 1/6
NUTEX Investments has been growing earnings at an average annual rate of 80.9%, while the Pharmaceuticals industry saw earnings growing at 10.5% annually. Revenues have been growing at an average rate of 9.9% per year. NUTEX Investments's return on equity is 1.4%, and it has net margins of 15711.5%.
Key information
80.9%
Earnings growth rate
70.5%
EPS growth rate
Pharmaceuticals Industry Growth | 12.4% |
Revenue growth rate | 9.9% |
Return on equity | 1.4% |
Net Margin | 15,711.5% |
Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How NUTEX Investments makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 23 | 0 | 71 | 21 | 0 |
31 Mar 23 | 0 | 101 | 19 | 0 |
31 Dec 22 | 0 | 131 | 16 | 0 |
30 Sep 22 | 0 | 115 | 15 | 0 |
30 Jun 22 | 0 | 99 | 14 | 0 |
31 Mar 22 | 0 | 56 | 14 | 0 |
31 Dec 21 | 0 | 13 | 13 | 0 |
30 Sep 21 | 0 | -10 | 14 | 0 |
30 Jun 21 | 0 | -32 | 14 | 0 |
31 Mar 21 | 0 | -3 | 16 | 0 |
31 Dec 20 | 0 | 26 | 19 | 0 |
30 Sep 20 | 0 | 15 | 18 | 0 |
30 Jun 20 | 0 | 4 | 18 | 0 |
31 Mar 20 | 0 | -2 | 14 | 0 |
31 Dec 19 | 1 | -8 | 10 | 0 |
Quality Earnings: NUTEX has a high level of non-cash earnings.
Growing Profit Margin: NUTEX's current net profit margins are lower than last year .
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NUTEX's earnings have grown significantly by 80.9% per year over the past 5 years.
Accelerating Growth: NUTEX's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: NUTEX had negative earnings growth (-28.6%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (2.6%).
Return on Equity
High ROE: NUTEX's Return on Equity (1.4%) is considered low.